Ebstein F	FIS_76293
Regulation der Proteostase  ein Fokus auf das Ubiquitin-Proteasomen-System
Biallelic variants in OTUD6B cause an intellectual disability syndrome associated with seizures and dysmorphic features.
MHC class I processing of the NY-ESO-1 antigen is regulated by Rpn10, Rpn13 and immunoproteasomes following non-lysine ubiquitination.
Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes.
Proteasome ?5i subunit deficiency affects opsonin synthesis and aggravates pneumococcal pneumonia.
De novo disruption of the proteasome regulatory subunit PSMD12 causes a syndromic neurodevelopmental disorder.
Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome.
Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells.
Contribution of the Unfolded Protein Response (UPR) to the Pathogenesis of Proteasome-Associated Autoinflammatory Syndromes (PRAAS)
ER-aminopeptidase 1 determines the processing and presentation of an immunotherapy-relevant melanoma epitope
Report of the first patient with a homozygous OTUD7A variant responsible for epileptic encephalopathy and related proteasome dysfunction
Biallelic variants in PSMB1 encoding the proteasome subunit ?6 cause impairment of proteasome function, microcephaly, intellectual disability, developmental delay and short stature
Proteasome subunit PSMC3 variants cause neurosensory syndrome combining deafness and cataract due to proteotoxic stress
SIGLEC1 (CD169) as a potential diagnostical screening marker for monogenic interferonopathies
The UbiquitinProteasome System in Immune Cells
HSCT corrects primary immunodeficiency and immune dysregulation in patients with POMP-related auto-inflammatory disease
Role of Proteasomes in Inflammation
Immunoproteasome impairment via ?5i/LMP7-deletion leads to sustained pancreatic injury from experimental pancreatitis.
Immunoproteasome Function in Normal and Malignant Hematopoiesis.
Neurodevelopmental Disorders (NDD) Caused by Genomic Alterations of the Ubiquitin-Proteasome System (UPS): the Possible Contribution of Immune Dysregulation to Disease Pathogenesis
Hematopoietic stem cell transplantation in a patient with proteasome-associated autoinflammatory syndrome (PRAAS)
Stankiewicz-Isidor syndrome: expanding the clinical and molecular phenotype
Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder
GestaltMatcher facilitates rare disease matching using facial phenotype descriptors
Protein kinase R is an innate immune sensor of proteotoxic stress via accumulation of cytoplasmic IL-24
Interferon receptor dysfunction in a child with malignant atrophic papulosis and CNS involvement
Proteostasis Perturbations and Their Roles in Causing Sterile Inflammation and Autoinflammatory Diseases
Immunoproteasomes control activation of innate immune signaling and microglial function.
The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease
Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling
Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS
Gain-of-function variants in the KDF1 gene cause hidradenitis suppurativa associated with ectodermal dysplasia by stabilizing I?B kinase ?.